Delphinus Medical Technologies, Inc. receives grant from the Internal Revenue Service.
The IRS, in conjunction with the Department of Health and Human Services, approved applications for projects that showed significant potential to produce new and cost-saving therapies, support jobs and increase U.S. competitiveness under the Qualifying Therapeutic Discovery Project program. The IRS determined the credit or grant amount for each approved project.
These awards have been given to companies to support research in 2009 and 2010 that can improve healthcare and fuel the economy. The funding is especially important to small firms that can use the money for research that otherwise might have been difficult to finance. Indeed, it’s difficult to come by traditional sources of financing for young companies such as venture capital nowadays.
Delphinus was awarded a grant of $244,4779 for FY 2009 and 2010. This award was made for the "Commercialization of SoftVue for Early Detection of Breast Cancer".